paclitaxel has been researched along with Anemia, Hemolytic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, R; Asai, H; Kamei, Y; Komatsu, S; Kusakabe, E; Mizuno, Y; Murakami, A; Nishiyama, K; Sugimori, W; Taguchi, K; Takada, Y; Yamasawa, H; Yamashita, M | 1 |
| Abebe, L; Bhagwati, N; Jain, D; Marcoullis, G; Talusan, R; Wiernik, PH | 1 |
2 other study(ies) available for paclitaxel and Anemia, Hemolytic
| Article | Year |
|---|---|
[A Case of Microangiopathic Hemolytic Anemia with Bone Marrow Carcinomatosis from Breast Cancer].
Topics: Anemia, Hemolytic; Antineoplastic Agents, Phytogenic; Biopsy; Bone Marrow Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Paclitaxel | 2018 |
Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case report.
Topics: Adenocarcinoma; Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Docetaxel; Female; Hemolysis; Humans; Methylprednisolone; Middle Aged; Paclitaxel; Plasmapheresis; Taxoids | 2002 |